663 related articles for article (PubMed ID: 28493895)
1. The cardiac glycoside ouabain activates NLRP3 inflammasomes and promotes cardiac inflammation and dysfunction.
Kobayashi M; Usui-Kawanishi F; Karasawa T; Kimura H; Watanabe S; Mise N; Kayama F; Kasahara T; Hasebe N; Takahashi M
PLoS One; 2017; 12(5):e0176676. PubMed ID: 28493895
[TBL] [Abstract][Full Text] [Related]
2. Glucose regulates hypoxia-induced NLRP3 inflammasome activation in macrophages.
Watanabe S; Usui-Kawanishi F; Karasawa T; Kimura H; Kamata R; Komada T; Inoue Y; Mise N; Kasahara T; Takahashi M
J Cell Physiol; 2020 Oct; 235(10):7554-7566. PubMed ID: 32115713
[TBL] [Abstract][Full Text] [Related]
3. Oxidized phosphatidylcholine induces the activation of NLRP3 inflammasome in macrophages.
Yeon SH; Yang G; Lee HE; Lee JY
J Leukoc Biol; 2017 Jan; 101(1):205-215. PubMed ID: 27256568
[TBL] [Abstract][Full Text] [Related]
4. OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation.
Marchetti C; Swartzwelter B; Gamboni F; Neff CP; Richter K; Azam T; Carta S; Tengesdal I; Nemkov T; D'Alessandro A; Henry C; Jones GS; Goodrich SA; St Laurent JP; Jones TM; Scribner CL; Barrow RB; Altman RD; Skouras DB; Gattorno M; Grau V; Janciauskiene S; Rubartelli A; Joosten LAB; Dinarello CA
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1530-E1539. PubMed ID: 29378952
[TBL] [Abstract][Full Text] [Related]
5. The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1β.
Bracey NA; Beck PL; Muruve DA; Hirota SA; Guo J; Jabagi H; Wright JR; Macdonald JA; Lees-Miller JP; Roach D; Semeniuk LM; Duff HJ
Exp Physiol; 2013 Feb; 98(2):462-72. PubMed ID: 22848083
[TBL] [Abstract][Full Text] [Related]
6. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
[TBL] [Abstract][Full Text] [Related]
7. NLRP3 inflammasome mediates interleukin-1β production in immune cells in response to Acinetobacter baumannii and contributes to pulmonary inflammation in mice.
Kang MJ; Jo SG; Kim DJ; Park JH
Immunology; 2017 Apr; 150(4):495-505. PubMed ID: 28032341
[TBL] [Abstract][Full Text] [Related]
8. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury.
Sandanger Ø; Ranheim T; Vinge LE; Bliksøen M; Alfsnes K; Finsen AV; Dahl CP; Askevold ET; Florholmen G; Christensen G; Fitzgerald KA; Lien E; Valen G; Espevik T; Aukrust P; Yndestad A
Cardiovasc Res; 2013 Jul; 99(1):164-74. PubMed ID: 23580606
[TBL] [Abstract][Full Text] [Related]
9. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G
J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215
[TBL] [Abstract][Full Text] [Related]
10. Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation.
Wang Y; Yan X; Mi S; Li Z; Wang Y; Zhu H; Sun X; Zhao B; Zhao C; Zou Y; Hu K; Ding X; Sun A; Ge J
J Cell Mol Med; 2017 Jan; 21(1):4-12. PubMed ID: 27785882
[TBL] [Abstract][Full Text] [Related]
11. The SGK1 inhibitor EMD638683, prevents Angiotensin II-induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation.
Gan W; Ren J; Li T; Lv S; Li C; Liu Z; Yang M
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):1-10. PubMed ID: 28986310
[TBL] [Abstract][Full Text] [Related]
12. P2X
Yin J; Wang Y; Hu H; Li X; Xue M; Cheng W; Wang Y; Li X; Yang N; Shi Y; Yan S
J Cell Mol Med; 2017 Nov; 21(11):2695-2710. PubMed ID: 28470940
[TBL] [Abstract][Full Text] [Related]
13. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.
Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S
Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403
[TBL] [Abstract][Full Text] [Related]
14. Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm.
Usui F; Shirasuna K; Kimura H; Tatsumi K; Kawashima A; Karasawa T; Yoshimura K; Aoki H; Tsutsui H; Noda T; Sagara J; Taniguchi S; Takahashi M
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):127-36. PubMed ID: 25378412
[TBL] [Abstract][Full Text] [Related]
15. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux.
He Y; Zeng MY; Yang D; Motro B; Núñez G
Nature; 2016 Feb; 530(7590):354-7. PubMed ID: 26814970
[TBL] [Abstract][Full Text] [Related]
16. Saturated Fatty Acids Undergo Intracellular Crystallization and Activate the NLRP3 Inflammasome in Macrophages.
Karasawa T; Kawashima A; Usui-Kawanishi F; Watanabe S; Kimura H; Kamata R; Shirasuna K; Koyama Y; Sato-Tomita A; Matsuzaka T; Tomoda H; Park SY; Shibayama N; Shimano H; Kasahara T; Takahashi M
Arterioscler Thromb Vasc Biol; 2018 Apr; 38(4):744-756. PubMed ID: 29437575
[TBL] [Abstract][Full Text] [Related]
17. NLRP3 inflammasome activation is associated with PM
Duan S; Wang N; Huang L; Zhao Y; Shao H; Jin Y; Zhang R; Li C; Wu W; Wang J; Feng F
Environ Toxicol; 2019 Nov; 34(11):1246-1254. PubMed ID: 31313453
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Inhibitory Capacities of 6-, 8- and 10-Gingerols/Shogaols on the Canonical NLRP3 Inflammasome-Mediated IL-1β Secretion.
Ho SC; Chang YH
Molecules; 2018 Feb; 23(2):. PubMed ID: 29466287
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
[TBL] [Abstract][Full Text] [Related]
20. Frontline Science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome.
Lopategi A; Flores-Costa R; Rius B; López-Vicario C; Alcaraz-Quiles J; Titos E; Clària J
J Leukoc Biol; 2019 Jan; 105(1):25-36. PubMed ID: 29601102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
